Gene may worsen cancer outcome by speeding metabolism of drugs

Some patients with breast cancer, lung cancer and leukemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds. The gene, called CYP3A7, is normally only active in infancy, but in some people it continues to be switched on into adulthood, and over-activates their metabolism.